AYTU BIOPHARMA, INC Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
AYTU BIOPHARMA, INC (AYTU) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of -4.40% for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-22.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2026-09-22
- AYTU BIOPHARMA, INC effective income tax rate reconciliation, other adjustments, percent for fiscal 2026 was -4.40%.
- AYTU BIOPHARMA, INC effective income tax rate reconciliation, other adjustments, percent for fiscal 2025 was -6.00%.
- AYTU BIOPHARMA, INC effective income tax rate reconciliation, other adjustments, percent for fiscal 2024 was -0.30%.
- AYTU BIOPHARMA, INC effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was -0.70%, a 7100.00% decline from fiscal 2022.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month as first filed |
|---|---|---|
| 2026-06-30 | -4.40% 10-K · filed 2026-09-22 | |
| 2025-06-30 | -6.00% 10-K · filed 2026-09-22 | |
| 2024-06-30 | -0.30% 10-K · filed 2025-09-23 | |
| 2023-06-30 | -0.70% 10-K · filed 2024-09-26 | 0.72% 10-K · filed 2023-10-12 |
| 2022-06-30 | 0.01% 10-K · filed 2023-10-12 | |
| 2021-06-30 | 1.13% 10-K · filed 2022-09-27 | |
| 2020-06-30 | 0.35% 10-K · filed 2021-09-28 | 0.37% 10-K · filed 2020-10-06 |
| 2019-06-30 | 0.71% 10-K · filed 2020-10-06 | 0.72% 10-K · filed 2019-09-26 |
| 2018-06-30 | 0.45% 10-K · filed 2019-09-26 | 0.97% 10-K · filed 2018-09-06 |
| 2017-06-30 | 0.44% 10-K · filed 2018-09-06 | 0.45% 10-K · filed 2017-08-31 |
| 2016-06-30 | 0.02% 10-K · filed 2017-08-31 | |
| 2015-06-30 | 0.03% 10-K · filed 2016-09-01 | -0.03% 10-K · filed 2015-09-28 |
| 2014-06-30 | -0.03% 10-K · filed 2015-09-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |